AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Marinomed Biotech AG

Share Issue/Capital Change Jul 29, 2022

749_rns_2022-07-29_e3f21044-c8de-457c-b6ee-585a5a2c6fa7.pdf

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

Adhoc service of the pressetext news agency Josefstädter Straße 44, 1080 Vienna, Austria, phone: +43 1 81140-0

publication: 29.07.2022 10:00 source: http://adhoc.pressetext.com/news/1659081600098 keywords: total votes

Change of total number of voting rights and capital according to article 135 section 1 BörseG

Marinomed Biotech AG: Change of total number of voting rights and capital according to article 135 section 1 BörseG

(Repetition of the announcement on July 21, 2022)

Korneuburg (pta009/29.07.2022/10:00) - Marinomed Biotech AG hereby announces that due to the exercise of the convertible bond with Nice & Green the total number of voting rights at the end of July 2022 has increased to 1,506,162 and the new stated capital amounts to EUR 1,506,162. The change of total voting rights has been effective since July 12, 2022.

emitter: Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Austria
contact person: Pascal Schmidt, CFO
phone: +43 2262 90300
e-mail: [email protected]
website: www.marinomed.com
ISIN(s): ATMARINOMED6 (share)
stock exchanges: official trade in Vienna

News transmitted by pressetext.adhoc. The emitter is responsible for the content.

Talk to a Data Expert

Have a question? We'll get back to you promptly.